FDA approves 1st mRNA flu shot, from Moderna
The first mRNA-based influenza vaccine has received federal approval in the United States.
29 independently sourced, verified news trends involving FDA.
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 2 news categories, from Jun 23, 2026 through Aug 7, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
The first mRNA-based influenza vaccine has received federal approval in the United States.
The FDA has issued a nationwide recall of levothyroxine sodium tablets due to the drug being described as subpotent.
Capricor Therapeutics shares are plummeting after FDA staff disputed the company's claims of Phase 3 success for its DMD cell therapy.
Capricor Therapeutics shares have plunged after FDA staff raised concerns regarding the efficacy and data of its Duchenne heart disease therapy.
Compounded GLP-1 weight‑loss drugs face mounting scrutiny as doctors and regulators flag safety concerns.
A July 2026 Cyclospora scare is reshaping menus, boosting local produce sales and testing public trust in the FDA.
Eli Lilly is planning a Q1 2027 FDA application for retatrutide following new data on weight loss and A1C improvements.
Amy’s Kitchen has recalled over 184,000 cans of vegan lentil soup across the U.S. due to a can defect that poses a spoilage risk.
FDA advisory committees have issued split decisions on the legal path for peptides amid high-profile advocacy for their wider availability.
An FDA advisory panel review of seven peptides is sparking a debate over longevity medicine, public health risks, and potential multibillion-dollar markets.
Federal health officials investigate multiple clusters of cyclosporiasis, with iceberg lettuce identified as the likely cause.
The FDA continues to target Taylor Farms lettuce as the source of a Cyclospora outbreak despite a retracted positive test result.
A multi-state iceberg lettuce recall is underway after the FDA linked a cyclosporis parasite outbreak to Taylor Farms.
General Mills is recalling 730,000 Pillsbury bread rolls across 18 states due to potential glass contamination.
A multistate cyclospora parasite outbreak has been linked to iceberg lettuce supplied by Taylor Farms to Taco Bell stores.
Taco Bell has removed lettuce from its U.S. menus following links to a cyclosporiasis outbreak traced to supplier Taylor Farms.
The FDA has approved Lipfendra, the first-of-its-kind oral PCSK9 inhibitor designed to significantly reduce cholesterol levels.
Sanofi's Sarclisa becomes the first cancer drug approved by the FDA for delivery via an on-body injector for multiple myeloma.
The FDA has issued a nationwide recall of 2.5 million bottles of steroid eye drops due to contamination concerns.
The FDA has approved Vera Therapeutics' drug Trutakna to treat primary IgA nephropathy, sparking a new market competition for kidney disease treatments.
The U.S. sunscreen market is shifting toward clinical necessity following the FDA's first approval of a new active ingredient in decades.
The FDA has upgraded a potato chip recall involving brands like Utz Zapp's and Dirty to Class I, its highest risk level, due to salmonella concerns.
The FDA has granted Philip Morris permission to market ZYN nicotine pouches as a safer, lower-risk alternative to cigarettes.
The FDA has launched a new initiative to accelerate the review process for new pharmaceutical manufacturing facilities.
Major online retailers are recalling TNVitamins moringa powder supplements nationwide due to potential salmonella contamination.
The FDA has classified a massive recall of Utz potato chip brands as a Class I risk due to potential salmonella contamination.
The FDA has granted broad first-line approval for Gilead's Trodelvy, signaling a shift away from traditional chemotherapy for aggressive breast cancer.
Wearable technology is shifting from general fitness tracking toward clinical healthcare integration and Medicare eligibility.
The U.S. Department of Health and Human Services is launching a department-wide effort to accelerate clinical trials and restore American leadership in medical research.